MPLUS (MPL)

MPLUS (MPL)

Created using Figma
M+plus is a supply chain platform with blockchain method in order to distribute pharmaceuticals and functional foods.
Apr 2, 2018
May 17, 2018
100% completed
Raised funds - no Data
past
Token Details
Accepted Currencies
ETH
Company Details
Registered Country
Malaysia
Additional Details
Categories
Platform

About MPLUS (MPL)

ICO (Initial Coin Offering), is a method for procuring funds by issuing and selling one's own digital tokens. It is not a form of transferring equity like stock procurement, but rather something like crowdfunding, where you simply sell tokens. At the time of this token sale, it is not recognized as "virtual currency". In other words, strictly speaking, ICO is not a "fundraising" method, but rather a "method of selling tokens". On the purchasing side, those giving money to the project would not be "investors," but rather "buyers of tokens". At the present time, m+plus token cannot be used as repayment of consideration for an unspecified person, as there is no exchange market for legal currency, bitcoin, or other existing virtual currency (see article 2, paragraph 5, item 1 of the Settlement of Capital Settlement Act), the above definition also applies to this ICO project.

Features

  • Blockchain- decentralized method used to distribute medical products and health food
  • Halal-certified products 
  • One of our company's products is "Silk Fibroin." Multi-function nano-level silk fibroin fat absorption product. It is officially permitted by the Malaysian government to be imported.

MPLUS (MPL) Roadmap

  • Q1-Q2 2018

  • ICO (Presales) begins;
    Head office facilities transfer to Malaysia;
    Affiliation of major pharmaceutical company in Malaysia;
    Establishment of liaison office in Japan (April 9th).
  • Q3-Q4 2018

  • Block chain distribution platform development begins;
    Halal certified silk fibroin will be determined.
  • Q1-Q2 2019

  • Super placenta medicine approval;
    Block chain platform internal operations commence;
    China, Thailand, Taiwan, South Korea and others join the distribution platform.
  • Q2-Q3 2019

  • Japan affiliates with other major pharmaceutical companies by joining the platform;
    Product manufacturing acceptance of Halal certification to Japanese companies;
    Product distribution to Islamic markets commences.

MPLUS (MPL) Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Hirotsugu Tanaka
MEDIC GROUP FUTURE SDN. BHD. CEO
unverified
Akihisa Ishida
Blockchain and Cryptocurrency Developer
unverified
Yoshihiro Yamada
Chief Designer
unverified
Sayako Kudo
Chief of Customer support team
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

A.k.mizanur Rahman
Financial Advisor
unverified

MPLUS (MPL) Last News

  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.